Literature DB >> 3927836

Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals.

J Mordenti.   

Abstract

The postdistribution half-lives of 10 cephalosporin and 2 monobactam antibiotics in humans were predicted from data obtained in other mammals. This forecasting was accomplished with the allometric equation t1/2 = aWb, where a is the y intercept and b is the slope obtained from the log-log plot of antibiotic half-life (t1/2) versus body weight (W). Dimensionless similarity criteria were used to produce a biological clock for ceftizoxime elimination. The creation of the biological clock, which measured physiologic time (heartbeats) rather than chronologic time (minutes), demonstrated that ceftizoxime half-life was identical in five mammals. This methodology will contribute to infectious disease research through a greater understanding of pharmacokinetic scaling in mammals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927836      PMCID: PMC180180          DOI: 10.1128/AAC.27.6.887

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Pharmacokinetics and metabolism of cefazedone in Wistar rat, beagle dog and rhesus monkey.

Authors:  H Sailer; H W Diekmann; H P Faro; A Garbe
Journal:  Arzneimittelforschung       Date:  1979

2.  Quantitative Relations in the Physiological Constitutions of Mammals.

Authors:  E F Adolph
Journal:  Science       Date:  1949-06-10       Impact factor: 47.728

3.  Scaling of renal functions in mammals.

Authors:  N A Edwards
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1975-09-01

4.  Organ weights in primates and other mammals.

Authors:  W R Stahl
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

5.  Metabolic fate of SCE-963, a new broad-spectrum cephalosporin, after parenteral administration in rats and dogs.

Authors:  S Tanayama; T Kondo; Y Kanai
Journal:  J Antibiot (Tokyo)       Date:  1978-07       Impact factor: 2.649

Review 6.  Scaling of physiological processes in homeothermic animals.

Authors:  W A Calder
Journal:  Annu Rev Physiol       Date:  1981       Impact factor: 19.318

7.  Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals.

Authors:  M Komiya; Y Kikuchi; A Tachibana; K Yano
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

8.  Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

9.  Blood levels and tissue concentrations of cefazedone in animals.

Authors:  E Dingeldein; H Wahlig
Journal:  Arzneimittelforschung       Date:  1979

10.  Pharmacokinetics of ceftizoxime in animals after parenteral dosing.

Authors:  T Murakawa; H Sakamoto; S Fukada; S Nakamoto; T Hirose; N Itoh; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more
  10 in total

Review 1.  Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors:  T Lavé; P Coassolo; B Reigner
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.

Authors:  V F Cosson; E Fuseau; C Efthymiopoulos; A Bye
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

Review 4.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Experimental implant-related osteomyelitis induced withStaphylococcus aureus.

Authors:  N H Nielsen; J Renneberg; B M Nürnberg; C Torholm
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-05

Review 6.  Relevance of animal models for clinical treatment.

Authors:  W Craig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

7.  Mouse model for evaluation of antibiotic treatment of acute and chronic infections.

Authors:  J Renneberg; M Walder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

8.  Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data.

Authors:  A Kurihara; H Naganuma; M Hisaoka; H Tokiwa; Y Kawahara
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex.

Authors:  G Gatti; J O Kahn; J Lifson; R Williams; L Turin; P A Volberding; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

10.  A urine-dependent human urothelial organoid offers a potential alternative to rodent models of infection.

Authors:  Harry Horsley; Dhanuson Dharmasena; James Malone-Lee; Jennifer L Rohn
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.